PhotoCure ASA (OSL:PHO)
kr 49.3 0.4 (0.82%) Market Cap: 1.34 Bil Enterprise Value: 1.05 Bil PE Ratio: 94.81 PB Ratio: 2.67 GF Score: 78/100

Q3 2022 Photocure ASA Earnings Call Transcript

Nov 02, 2022 / 01:00PM GMT
Release Date Price: kr99.45 (+7.28%)
Daniel Schneider
Photocure ASA - President & CEO

Well, good afternoon, all those in Europe, and good morning to those in the United States. Welcome to Photocure ASA's Third Quarter 2022 Results. I'm Dan Schneider, President and CEO. Joining me today will be Erik Dahl, CFO. Just a reminder, the usual disclaimers are in place for today's presentation.

So let's talk about the third quarter 2022 highlights. There has been some recent developments. We'll get into those today, some exciting positive things happening to the business. We got positive momentum on the Saphira launch, which launched late third quarter. And as we said in the presentation and in the report, we already placed 6 of those towers.

We've also recently announced through the quarterly the improved Medicare access and reimbursement. This is something the organization has been working on for years, getting access to not only the hospital outpatient, but the ambulatory surgery centers, which are an important growing segment of business in cystoscopy specifically and we see a tremendous opportunity.

But

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot